CSIMarket Company Name, Ticker, Industry, else..
 
Lexaria Bioscience Corp   (NASDAQ: LEXX)
 
Price: $9.3700 $-4.78 -33.781%
Day's High: $11.09000015258789 Week Perf: -24.89 %
Day's Low: $ 8.81 30 Day Perf: 77.8 %
Volume (M): 121,237 52 Wk High: $ 14.37
Volume (M$): $ 0 52 Wk Avg: $1.70
Open: $11.09 52 Wk Low: $0.35



 Market Capitalization (Millions $) 16
 Shares Outstanding (Millions) 2
 Employees 7
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -8
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Business Description


Lexaria Bioscience Corp is a biotechnology company based in Canada. The company focuses on the development of drug delivery technology that enhances the performance and effectiveness of pharmaceuticals. Lexaria's patented DehydraTECH platform uses lipid-based carriers to deliver drugs and other bioactive compounds more efficiently into the bloodstream. This technology has shown potential in improving the delivery of various substances, including cannabinoids, nicotine, and nonsteroidal anti-inflammatory drugs. Lexaria is actively involved in partnerships and collaborations with other companies to develop and commercialize products utilizing its technology. The company aims to provide improved delivery solutions that can enhance the effectiveness and consumer experience of various pharmaceuticals and nutraceuticals.


   Company Address: #100 – 740 McCurdy Road Kelowna 0 BC
   Company Phone Number: 765.6424   Stock Exchange / Ticker: NASDAQ LEXX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CPMD      0% 
CVSI   -13.5%    
ETST        1.06% 
GCAN   -23%    
IGC   -3.37%    
LIFD      0% 
• View Complete Report
   



Management Announcement

Lexaria Bioscience Corp's Revolutionary Drug-Delivery System: The Future of Medical Breakthroughs and Profitability.

Published Thu, Jan 11 2024 1:30 PM UTC

as Profitable: Lexaria Bioscience s Breakthrough Drug-Delivery System Revolutionizes Medical Treatments
Lexaria Bioscience Corp. (NASDAQ: LEXX) has recently revealed its groundbreaking proprietary drug-delivery system, which has the potential to revolutionize the way molecules enter the bloodstream and offer exciting new possibilities for GLP-1 Diabetes and weight-loss ...
Management Announcement

Lexaria Bioscience Corp. Revolutionizes Drug Delivery for Type 2 Diabetes Treatment

Published Tue, Jan 9 2024 1:30 PM UTC

Lexaria Bioscience Corp. (NASDAQ: LEXX) has recently announced an exciting breakthrough in drug delivery technology, elevating the efficacy and delivery of GLP-1 agonists through its proprietary platform. The company s achievements have been highlighted in an editorial published by NetworkNewsWire, a leading financial news and content distribution platform.
The innovativ...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 79.87
Price to Sales (Expected) -
Price to Book 3.27
PEG (TTM) -

Financial Strength Current
Quick Ratio 5.2
Working Capital Ratio 5.93
Leverage Ratio (MRQ) 0.08
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -5.4 $
Revenues (TTM) 0.12 $
Cash Flow (TTM) 0.32 $
Cash 2.2 $
Book Value 2.87 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,105,778
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.